| 0.8 |
2.4 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.8 |
2.3 |
GO:2001190 |
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.6 |
2.4 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.6 |
2.8 |
GO:1902228 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.5 |
1.6 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.5 |
1.5 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.4 |
1.3 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.4 |
3.3 |
GO:0009753 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.4 |
0.7 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.3 |
1.0 |
GO:2000724 |
nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.3 |
6.8 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 |
0.3 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.3 |
1.3 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.3 |
1.3 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.3 |
1.8 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.3 |
1.2 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.3 |
1.4 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 |
2.3 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.3 |
1.6 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.3 |
0.8 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.3 |
1.0 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.3 |
2.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 |
2.2 |
GO:0045959 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.2 |
1.0 |
GO:0098942 |
regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.2 |
1.7 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.2 |
1.0 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.2 |
1.4 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.2 |
1.3 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.2 |
0.2 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.2 |
1.5 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 |
1.0 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.2 |
2.8 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
0.2 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 |
1.0 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 |
1.9 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.2 |
0.8 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.2 |
0.7 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.2 |
1.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.2 |
0.7 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 |
2.2 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.2 |
0.9 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.2 |
0.9 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 |
2.6 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
0.2 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.2 |
0.7 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.2 |
1.5 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.2 |
0.8 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
0.8 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
0.5 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.2 |
1.3 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
1.2 |
GO:0086047 |
membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.2 |
0.6 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.2 |
0.9 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.2 |
0.5 |
GO:1902996 |
regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.2 |
0.6 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.2 |
0.2 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.1 |
1.0 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.4 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) olefin metabolic process(GO:1900673) |
| 0.1 |
1.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
1.6 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
0.4 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.1 |
1.0 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.3 |
GO:0043542 |
endothelial cell migration(GO:0043542) |
| 0.1 |
0.4 |
GO:2000523 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.1 |
1.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.6 |
GO:0050705 |
regulation of interleukin-1 alpha secretion(GO:0050705) |
| 0.1 |
0.8 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.5 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.1 |
0.5 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 |
0.1 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.1 |
0.6 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.1 |
0.8 |
GO:0048389 |
intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 0.1 |
0.9 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.1 |
0.6 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.6 |
GO:0042268 |
regulation of cytolysis(GO:0042268) positive regulation of cytolysis(GO:0045919) |
| 0.1 |
1.3 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.5 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.1 |
0.9 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.1 |
0.7 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.1 |
0.7 |
GO:0061364 |
apoptotic process involved in luteolysis(GO:0061364) |
| 0.1 |
0.5 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.1 |
1.6 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
4.1 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 |
1.9 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.4 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 |
1.3 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 |
0.5 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.3 |
GO:0007037 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.1 |
0.5 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.1 |
0.1 |
GO:2000866 |
positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.1 |
1.4 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.1 |
0.5 |
GO:0072299 |
visceral serous pericardium development(GO:0061032) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.1 |
0.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.3 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.8 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.5 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.1 |
0.8 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.1 |
2.3 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 |
0.6 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.3 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.2 |
GO:0051466 |
positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.1 |
0.2 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.1 |
0.7 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.8 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.1 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.1 |
0.7 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.4 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.1 |
0.3 |
GO:0048597 |
B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.1 |
0.2 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 |
0.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.1 |
0.3 |
GO:0060981 |
cell migration involved in coronary angiogenesis(GO:0060981) |
| 0.1 |
0.5 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
0.3 |
GO:0098972 |
dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 |
0.8 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
1.0 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 |
1.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.3 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 |
0.9 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 |
1.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.3 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
| 0.1 |
0.3 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 |
0.1 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 |
0.6 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.1 |
0.7 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 |
0.4 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.7 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.1 |
3.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.6 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.4 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.1 |
0.5 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.3 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.1 |
0.5 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.2 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.1 |
0.3 |
GO:1903410 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.1 |
0.2 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.1 |
0.3 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 |
0.3 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.2 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 0.1 |
0.3 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.1 |
0.3 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 |
1.7 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.1 |
0.7 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.1 |
1.6 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.4 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 |
0.3 |
GO:0060585 |
vein smooth muscle contraction(GO:0014826) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 |
0.2 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 |
0.2 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.1 |
0.3 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 |
0.3 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
0.2 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.1 |
0.3 |
GO:0044010 |
iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) positive regulation of bone mineralization involved in bone maturation(GO:1900159) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 0.1 |
0.3 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 |
0.3 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
0.3 |
GO:2001301 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 |
1.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.3 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 |
0.5 |
GO:0034371 |
chylomicron remodeling(GO:0034371) |
| 0.1 |
1.8 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
0.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
1.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
1.1 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.1 |
0.2 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.2 |
GO:0032764 |
negative regulation of mast cell cytokine production(GO:0032764) |
| 0.1 |
0.7 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
1.0 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 |
0.2 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 |
0.6 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.2 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
1.4 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.1 |
0.8 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.2 |
GO:1903352 |
L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.7 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
1.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
11.9 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.1 |
0.8 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
0.2 |
GO:1904744 |
regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
0.2 |
GO:0051446 |
positive regulation of meiotic cell cycle(GO:0051446) |
| 0.1 |
0.4 |
GO:1904995 |
negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
0.5 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.4 |
GO:1904383 |
response to sodium phosphate(GO:1904383) |
| 0.1 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.6 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
0.1 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.1 |
0.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.7 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.1 |
0.6 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.1 |
0.6 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.6 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.4 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
0.2 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.1 |
0.3 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.1 |
0.7 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.3 |
GO:0010817 |
regulation of hormone levels(GO:0010817) |
| 0.1 |
0.3 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
1.3 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 |
0.3 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.3 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
0.3 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.1 |
1.7 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.1 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 |
0.5 |
GO:0030324 |
lung development(GO:0030324) |
| 0.1 |
0.1 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
0.3 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 |
0.2 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.1 |
1.1 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
1.2 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.1 |
0.5 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.2 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 |
1.9 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.1 |
0.3 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.1 |
0.3 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
0.3 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.1 |
0.4 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) |
| 0.1 |
0.3 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.1 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 |
0.3 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 |
0.5 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.2 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
0.3 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.4 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.7 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
0.4 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
0.3 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
0.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
0.6 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 |
0.2 |
GO:0007276 |
gamete generation(GO:0007276) |
| 0.1 |
0.1 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.1 |
0.5 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
0.7 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 |
0.4 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 |
0.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
0.8 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
0.3 |
GO:0071888 |
macrophage apoptotic process(GO:0071888) |
| 0.1 |
0.2 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.1 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.1 |
0.2 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.1 |
0.6 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.2 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.1 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.1 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.1 |
1.5 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.1 |
0.2 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.1 |
0.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.3 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 |
0.2 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.1 |
GO:0002902 |
regulation of B cell apoptotic process(GO:0002902) negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.3 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.1 |
0.4 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.1 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.8 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.6 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.1 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.1 |
0.3 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.5 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 |
0.5 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.3 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.1 |
0.4 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.4 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.1 |
GO:0097069 |
response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.1 |
0.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.3 |
GO:0031179 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.1 |
0.1 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 |
0.2 |
GO:0002415 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.0 |
0.0 |
GO:1990641 |
regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) response to iron ion starvation(GO:1990641) |
| 0.0 |
0.1 |
GO:1904892 |
regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
| 0.0 |
0.1 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.0 |
1.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.5 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.0 |
0.1 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.0 |
0.2 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.0 |
0.7 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.1 |
GO:0034130 |
toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.0 |
0.1 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 0.0 |
0.2 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.0 |
0.3 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.2 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.0 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
1.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
1.3 |
GO:0071380 |
cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.0 |
2.0 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.7 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.2 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 |
0.5 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 |
0.6 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.1 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.0 |
0.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.0 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 |
0.1 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.0 |
0.0 |
GO:0015820 |
leucine transport(GO:0015820) |
| 0.0 |
0.5 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.5 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.0 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) |
| 0.0 |
0.7 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.1 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.0 |
0.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.4 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.0 |
0.2 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.0 |
0.4 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.0 |
0.8 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
0.5 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.1 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.0 |
0.3 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.0 |
0.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.0 |
0.2 |
GO:0003402 |
planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.0 |
0.0 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.0 |
0.2 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.4 |
GO:0050428 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.0 |
0.3 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.0 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.0 |
0.3 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.0 |
0.1 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.0 |
0.2 |
GO:2000611 |
positive regulation of thyroid hormone generation(GO:2000611) |
| 0.0 |
0.0 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.0 |
0.3 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.0 |
5.1 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.2 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.2 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.0 |
0.2 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.0 |
0.2 |
GO:0032966 |
negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.0 |
0.2 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.0 |
0.1 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.0 |
0.3 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.0 |
0.7 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.2 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.2 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.0 |
0.0 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.0 |
0.3 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.0 |
1.7 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 |
0.2 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.0 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.0 |
1.2 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.0 |
0.5 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.2 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.0 |
0.8 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.0 |
0.1 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
| 0.0 |
0.1 |
GO:0042489 |
negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.0 |
0.1 |
GO:0021551 |
central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) |
| 0.0 |
0.1 |
GO:0021571 |
rhombomere 5 development(GO:0021571) |
| 0.0 |
0.2 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.0 |
0.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 |
0.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.1 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.0 |
0.1 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.2 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.0 |
0.5 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.1 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.0 |
0.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.3 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 0.0 |
0.2 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
| 0.0 |
0.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 |
0.2 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 |
0.4 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.0 |
9.1 |
GO:0007565 |
female pregnancy(GO:0007565) |
| 0.0 |
0.7 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 |
0.4 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.0 |
0.1 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 |
0.3 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.1 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.2 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.0 |
0.3 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.0 |
0.2 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 |
1.1 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.5 |
GO:1900116 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.1 |
GO:0032364 |
oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
| 0.0 |
0.2 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.0 |
0.1 |
GO:2000687 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.0 |
1.0 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.1 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.0 |
0.1 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.2 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.2 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
| 0.0 |
0.1 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.0 |
0.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.1 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.0 |
0.1 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.0 |
0.0 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.2 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.0 |
0.1 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.0 |
0.1 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.0 |
0.6 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.0 |
0.2 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 |
0.1 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.0 |
0.0 |
GO:0002885 |
positive regulation of hypersensitivity(GO:0002885) |
| 0.0 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.2 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.0 |
0.2 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.3 |
GO:0072178 |
nephric duct morphogenesis(GO:0072178) |
| 0.0 |
0.0 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.0 |
1.0 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.1 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.0 |
0.4 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.3 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.1 |
GO:1905146 |
lysosomal protein catabolic process(GO:1905146) |
| 0.0 |
0.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.0 |
0.4 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.0 |
1.6 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.1 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 |
0.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.0 |
0.1 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.0 |
0.3 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.0 |
0.2 |
GO:0030888 |
regulation of B cell proliferation(GO:0030888) |
| 0.0 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.4 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 |
0.1 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.0 |
3.4 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.0 |
0.3 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
0.1 |
GO:0051659 |
maintenance of mitochondrion location(GO:0051659) |
| 0.0 |
0.3 |
GO:0001961 |
positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
| 0.0 |
0.1 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.0 |
0.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.1 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 |
0.1 |
GO:0010734 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.0 |
0.2 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.0 |
0.0 |
GO:0050906 |
detection of stimulus involved in sensory perception(GO:0050906) |
| 0.0 |
0.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.0 |
0.2 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.0 |
0.5 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.0 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 |
0.1 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) prolyl-tRNA aminoacylation(GO:0006433) |
| 0.0 |
0.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.2 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.0 |
0.1 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.0 |
0.1 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.0 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.0 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.0 |
0.1 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.2 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.3 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.0 |
0.1 |
GO:0071356 |
response to tumor necrosis factor(GO:0034612) cellular response to tumor necrosis factor(GO:0071356) |
| 0.0 |
0.1 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.0 |
0.6 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 |
0.1 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.0 |
0.1 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.0 |
0.1 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.3 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.4 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 |
0.2 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
0.4 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.1 |
GO:0006086 |
acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
| 0.0 |
0.2 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.0 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.0 |
0.6 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
| 0.0 |
0.2 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.0 |
0.4 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.2 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 |
0.2 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
0.1 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 |
0.4 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.0 |
0.1 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.1 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.0 |
0.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 |
2.7 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.5 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 |
0.2 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.0 |
0.6 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 |
0.1 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.0 |
0.3 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.1 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.0 |
0.1 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.0 |
0.5 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.0 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.0 |
0.1 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.0 |
0.2 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.0 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) |
| 0.0 |
0.1 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 |
0.8 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.0 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.0 |
0.2 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
1.1 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.8 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.0 |
0.7 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.0 |
0.1 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 |
0.0 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 |
0.3 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.3 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.1 |
GO:0030421 |
defecation(GO:0030421) |
| 0.0 |
0.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.1 |
GO:1903615 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.0 |
0.1 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.6 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
1.7 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 |
0.6 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.1 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.1 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
1.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.2 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.0 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.0 |
0.8 |
GO:0051905 |
establishment of pigment granule localization(GO:0051905) |
| 0.0 |
0.1 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.0 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 |
0.0 |
GO:1904815 |
negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.0 |
0.2 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.0 |
0.1 |
GO:0000075 |
cell cycle checkpoint(GO:0000075) |
| 0.0 |
0.0 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.0 |
0.2 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.0 |
1.1 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.0 |
0.7 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.2 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.1 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.0 |
0.1 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.0 |
0.2 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.0 |
0.0 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.0 |
0.2 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.2 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 |
0.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
0.1 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.0 |
0.3 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.0 |
1.9 |
GO:0006081 |
cellular aldehyde metabolic process(GO:0006081) |
| 0.0 |
1.4 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.2 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.4 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.2 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.0 |
0.0 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.0 |
0.2 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.0 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.0 |
0.4 |
GO:0006853 |
carnitine shuttle(GO:0006853) |
| 0.0 |
0.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.0 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.6 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 |
0.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.0 |
0.4 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.1 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.1 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.0 |
0.1 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.0 |
0.3 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.0 |
0.2 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 |
0.0 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.0 |
0.1 |
GO:0010875 |
positive regulation of cholesterol efflux(GO:0010875) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.7 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.0 |
0.6 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.0 |
0.1 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
1.1 |
GO:0042267 |
natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 |
0.1 |
GO:0036512 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.0 |
0.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.0 |
0.0 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.0 |
0.1 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.0 |
0.1 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.0 |
0.3 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.0 |
0.3 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.1 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.0 |
0.4 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.1 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.0 |
0.2 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.4 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.1 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 |
0.8 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.1 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.0 |
0.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 |
0.1 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.0 |
1.1 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.1 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.0 |
0.1 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 |
0.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.2 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.1 |
GO:0031333 |
negative regulation of protein complex assembly(GO:0031333) |
| 0.0 |
0.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.2 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.0 |
0.0 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 |
0.1 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.1 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.0 |
0.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.0 |
0.1 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.0 |
GO:0071877 |
regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.0 |
0.1 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.0 |
0.0 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.0 |
0.1 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.0 |
0.4 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.1 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
0.1 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.1 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.0 |
0.2 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.0 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.0 |
0.0 |
GO:0060922 |
atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.0 |
0.3 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
0.3 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 |
0.0 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.0 |
0.3 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.0 |
0.1 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.0 |
0.0 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 |
0.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.0 |
GO:0033034 |
positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
| 0.0 |
0.0 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.0 |
0.0 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.0 |
0.1 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 |
0.1 |
GO:0040031 |
snRNA pseudouridine synthesis(GO:0031120) snRNA modification(GO:0040031) |
| 0.0 |
0.3 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.0 |
0.1 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.0 |
2.1 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.1 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.1 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.2 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.1 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 |
0.1 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 |
0.1 |
GO:0021514 |
ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.0 |
0.2 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 |
0.7 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.3 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.3 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.0 |
0.1 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.0 |
0.0 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.1 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.0 |
0.4 |
GO:0021782 |
glial cell development(GO:0021782) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.1 |
GO:1900042 |
regulation of interleukin-2 secretion(GO:1900040) positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.0 |
0.0 |
GO:0044335 |
canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
| 0.0 |
0.7 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.4 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.0 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.0 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.1 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.0 |
0.1 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) |
| 0.0 |
0.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.0 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.0 |
0.4 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.1 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.0 |
0.1 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.2 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 |
0.2 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.0 |
GO:0007618 |
mating(GO:0007618) |
| 0.0 |
0.4 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) ureteric bud morphogenesis(GO:0060675) |
| 0.0 |
0.1 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.0 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.9 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.0 |
0.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.2 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.0 |
0.0 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.0 |
0.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.2 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 |
0.0 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.0 |
0.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.0 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.0 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.0 |
0.1 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.0 |
0.1 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.0 |
0.1 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.0 |
0.2 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 |
0.0 |
GO:0006040 |
amino sugar metabolic process(GO:0006040) |
| 0.0 |
0.0 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.0 |
0.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.0 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
0.0 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.0 |
0.1 |
GO:0060043 |
regulation of cardiac muscle cell proliferation(GO:0060043) |
| 0.0 |
0.0 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) sarcomerogenesis(GO:0048769) |
| 0.0 |
0.0 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.0 |
0.1 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 |
0.1 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.0 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.1 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.0 |
0.2 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.0 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.0 |
0.0 |
GO:0071431 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 |
0.1 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
0.1 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.0 |
0.1 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.0 |
GO:0045080 |
positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.0 |
0.0 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.0 |
0.0 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.0 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 |
0.0 |
GO:1900164 |
determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
| 0.0 |
0.1 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.0 |
0.0 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.2 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.0 |
0.0 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.0 |
0.0 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |